ArticleBlood cancer journal2026

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

John Sharp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.